Emerge Bioscience Pte. Ltd. logo

Emerge Bioscience Pte. Ltd.

11 Live Marks
Pvt. Ltd.
First Filed:Feb 12, 2026Latest Filed:Oct 31, 2026Address:Singapore, SG

Portfolio Overview

Top Classes

Class 5
Pharmaceuticals
11(100%)
Class 42
Software, IT Services & Scientific Research
4(36%)
Class 44
Medical, beauty and agricultural services
4(36%)

TTAB Proceedings

No litigation activity

Top Firms

McDonnell Boehnen Hulbert & ...(Oct 2026)
11

Trademark Portfolio

11 results

(current & previous marks)

Refine by Mark/Description🔽
Filed
Registered
Last Activity
DULYZIFT
DULYZIFT
Trademark
Word
PENDING
Owner:
Serial:50193192
Filed:Oct 31, 2026
Classes:5, 42, 44
Description: Class 5: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; biologics; biosimilars; dulaglutide biosimilars; pharmaceutical preparations for the treatment of diabetes; pharmaceutical preparations for for glycemic control; pharmaceutical preparations for controlling blood sugar; biosimilars for glycemic control; pharmaceutical preparations, namely, GLP-1 receptor agonists for glycemic control; pharmaceutical preparations, namely, injectable dulaglutide biosimilars; pharmaceutical preparations, namely, injectable biosimilars for the treatment of diabetes; pharmaceutical preparations, namely, injectable biosimilars for glycemic control; pharmaceutical preparations, namely, injectable biosimilars for controlling blood sugar; pharmaceutical preparations, namely, injectable GLP-1 receptor agonists for glycemic control; pharmaceutical preparations, namely, injectable GLP-1 receptor agonists for controlling blood sugar; injectors sold filled with dulaglutide biosimilars; injectors sold filled with pharmaceutical preparations for the treatment of diabetes; injectors sold filled with pharmaceutical preparations for glycemic control; injectors sold filled with pharmaceutical preparations for controlling blood sugar; injectors sold filled with biosimilars for glycemic control; injectors sold filled with GLP-1 receptor agonists for glycemic control; injectors sold filled with GLP-1 receptor agonists for controlling blood sugar
Class 42: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to diabetes and diabetes treatments; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of diabetes and diabetes treatments
Class 44: Providing medical information; providing health information; providing medical information in the field of diabetes and diabetes treatments; providing health information in the field of diabetes and diabetes treatments; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
XENLETA
XENLETA
Trademark
Word
PENDING
Owner:
Serial:50193204
Filed:Oct 31, 2026
Classes:5, 42, 44
Description: Class 5: Pharmaceutical preparations for treating respiratory illnesses; antibiotics; pharmaceutical preparations for the treatment of pneumonia and bacterial infections; pharmaceutical preparations for the treatment of pneumonia; pharmaceutical preparations for the treatment of bacterial infections; anti-infectives
Class 42: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to respiratory illnesses and treatments for respiratory illnesses; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of respiratory illnesses and treatments for respiratory illnesses
Class 44: Providing medical information; providing health information; providing medical information in the field of respiratory illnesses and treatments for respiratory illnesses; providing health information in the field of respiratory illnesses and treatments for respiratory illnesses; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
RINLYGRA
RINLYGRA
Trademark
Word
PENDING
Owner:
Serial:50004857
Filed:Jul 21, 2026
Classes:5, 42, 44
Description: Class 5: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
Class 42: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to diabetes; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of diabetes
Class 44: Providing medical information; providing health information; providing medical information in the field of diabetes; providing health information in the field of diabetes; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
YUBAZYN
YUBAZYN
Trademark
Word
PENDING
Owner:
Serial:50004847
Filed:Jul 21, 2026
Classes:5, 42, 44
Description: Class 5: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
Class 42: Providing information in the field of scientific and medical research related to pharmaceuticals; providing information in the field of scientific and medical research related to diabetes; research and development of pharmaceuticals; research and development of pharmaceuticals in the field of diabetes
Class 44: Providing medical information; providing health information; providing medical information in the field of diabetes; providing health information in the field of diabetes; medical and pharmaceutical consultation; pharmaceutical advice; providing information to patients in the field of administering medications; individual medical counseling services provided to patients; providing personal support services for families of patients with life threatening disorders, namely, health counseling services
GARLINSY
GARLINSY
Trademark
Combined
PENDING
Owner:
Serial:99821567
Filed:May 13, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
GARLINSY
GARLINSY
Trademark
Word
PENDING
Owner:
Serial:99680961
Filed:Mar 3, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
IGLANBA
IGLANBA
Trademark
Combined
PENDING
Owner:
Serial:99680976
Filed:Mar 3, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
GARZULYS
GARZULYS
Trademark
Combined
PENDING
Owner:
Serial:99672171
Filed:Feb 26, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin aspart; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin aspart; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin aspart; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
HUMSENRY
HUMSENRY
Trademark
Word
PENDING
Owner:
Serial:99672219
Filed:Feb 26, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin lispro; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin lispro; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin lispro; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
LISVOAY
LISVOAY
Trademark
Combined
PENDING
Owner:
Serial:99672241
Filed:Feb 26, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin lispro; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin lispro; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin lispro; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
IGLANBA
IGLANBA
Trademark
Word
PENDING
Owner:
Serial:99649970
Filed:Feb 12, 2026
Classes:5
Description: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics